Internal Medicine, Nephrology · Brooklyn, NY
NPI
1598035081
Since 2011
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
849 57th St Ste 7
Brooklyn, NY, 11220
Phone (718) 576-6678
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
459 services
Medicare patients, 2024
95
Average age 75
Drug cost, 2024
$3.2M
11,330 prescriptions
Company payments, 2025
$2,639
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Li Yang was code 90960 (esrd related services (not dialysis)), 90 times for 15 patients. In total Li Yang billed 459 services in 24 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 90 | 15 | $310.20 | $28K |
| 99213 Office E&M - Established | Office | 86 | 39 | $79.54 | $6,840 |
| 96372 Injection Administration | Office | 39 | 12 | $11.45 | $447 |
| 99212 Office E&M - Established | Office | 31 | 11 | $42.01 | $1,302 |
| 36415 Venipuncture Blood Collection | Office | 30 | 20 | $8.65 | $260 |
| 81000 Clinical Chemistry | Office | 22 | 18 | $3.94 | $86.68 |
By year: 2022 $110K for 734 services; 2023 $80K for 604 services; 2024 $56K for 459 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 30 | 20 | $8.65 | $260 |
| 81000 Clinical Chemistry | 22 | 18 | $3.94 | $86.68 |
Medicare prescription drug claims, 2024
In 2024, the drug Li Yang prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 731 prescriptions and refills. In total Li Yang wrote 11,330 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 731 | 815 | 107 | $273K |
| Amlodipine Besylate Generic | 505 | 627 | 98 | $1,991 |
| Tamsulosin Hcl Generic | 505 | 580 | 79 | $2,709 |
| Losartan Potassium Generic | 454 | 557 | 90 | $2,040 |
| Allopurinol Generic | 432 | 511 | 59 | $2,132 |
| Finasteride Generic | 422 | 505 | 67 | $1,626 |
| Farxiga Dapagliflozin Propanediol | 380 | 424 | 69 | $235K |
| Nifedipine Er Nifedipine | 314 | 352 | 46 | $2,738 |
| Sevelamer Carbonate Generic | 312 | 356 | 47 | $33K |
| Hydralazine Hcl Generic | 288 | 327 | 44 | $2,737 |
| Labetalol Hcl Generic | 274 | 315 | 42 | $4,885 |
| Acarbose Generic | 264 | 301 | 39 | $5,171 |
| Tradjenta Linagliptin | 253 | 297 | 49 | $150K |
| Retacrit Epoetin Alfa-Epbx | 237 | 239 | 41 | $133K |
| Glipizide Er Glipizide | 225 | 255 | 33 | $1,787 |
Brand drugs: 3,474 claims; generic drugs: 7,817 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Li Yang $2,639 ($2,639 in general payments such as food, travel and fees) from 20 companies. The largest payer was Travere Therapeutics, Inc. with $300.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 9 | $300 |
| Amgen Inc. AMGN | 14 | $288 |
| Calliditas Therapeutics US Inc. | 13 | $286 |
| Ardelyx, Inc. ARDX | 10 | $228 |
| Esperion Therapeutics, Inc. ESPR | 11 | $221 |
| GlaxoSmithKline, LLC. GSK | 6 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $141 |
| Akebia Therapeutics Inc AKBA | 6 | $135 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $116 |
| OPKO Pharmaceuticals, LLC | 6 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.